|
1
|
Atrophic gastritis as a cause of hyperhomocysteinaemia.
|
Aliment Pharmacol Ther
|
2004
|
2.09
|
|
2
|
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis.
|
Aliment Pharmacol Ther
|
2006
|
1.76
|
|
3
|
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial.
|
Aliment Pharmacol Ther
|
2003
|
1.59
|
|
4
|
The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy.
|
Aliment Pharmacol Ther
|
2001
|
1.52
|
|
5
|
Review article: breath testing for human liver function assessment.
|
Aliment Pharmacol Ther
|
2002
|
1.19
|
|
6
|
Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus.
|
Eur J Gastroenterol Hepatol
|
1998
|
1.16
|
|
7
|
Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.
|
Aliment Pharmacol Ther
|
2004
|
1.04
|
|
8
|
Extradigestive manifestations of Helicobacter pylori gastric infection.
|
Gut
|
1999
|
1.03
|
|
9
|
Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection.
|
Aliment Pharmacol Ther
|
2005
|
1.01
|
|
10
|
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study.
|
Digestion
|
2001
|
0.99
|
|
11
|
The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure.
|
Transplant Proc
|
2005
|
0.89
|
|
12
|
Insulin-dependent diabetes mellitus affects eradication rate of Helicobacter pylori infection.
|
Eur J Gastroenterol Hepatol
|
1999
|
0.86
|
|
13
|
Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication.
|
Aliment Pharmacol Ther
|
2002
|
0.86
|
|
14
|
13C-breath tests in the study of microsomal liver function.
|
Eur Rev Med Pharmacol Sci
|
2004
|
0.85
|
|
15
|
Association between Helicobacter pylori cytotoxic type I CagA-positive strains and migraine with aura.
|
Cephalalgia
|
2000
|
0.85
|
|
16
|
Characterization of gene expression profile in rat Kupffer cells stimulated with IFN-alpha or IFN-gamma.
|
Dig Liver Dis
|
2006
|
0.84
|
|
17
|
Helicobacter pylori infection affects eosinophilic cationic protein in the gastric juice of patients with idiopathic chronic urticaria.
|
Int Arch Allergy Immunol
|
2001
|
0.84
|
|
18
|
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa.
|
Scand J Gastroenterol
|
2001
|
0.83
|
|
19
|
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation.
|
Aliment Pharmacol Ther
|
2004
|
0.83
|
|
20
|
Efficacy of a multistep strategy for Helicobacter pylori eradication.
|
Aliment Pharmacol Ther
|
2000
|
0.83
|
|
21
|
Advances in extracorporeal detoxification by MARS dialysis in patients with liver failure.
|
Curr Med Chem
|
2003
|
0.81
|
|
22
|
Efficacy and tolerability of antibiotics in patients undergoing H. pylori eradication.
|
Hepatogastroenterology
|
2001
|
0.81
|
|
23
|
Serum macrophage migration inhibitory factor (MIF) in the intercritical phase of hereditary periodic fevers and its relationship with the MIF-173G/C polymorphism.
|
Scand J Rheumatol
|
2007
|
0.81
|
|
24
|
Study of liver function in healthy elderly subjects using the 13C-methacetin breath test.
|
Aliment Pharmacol Ther
|
2003
|
0.81
|
|
25
|
Re: "Chronic Helicobacter pylori infection and migraine: a case-control study" (Pinessi L, Savi L, Pellicano R, et al. Headache. 2000;40:836-839).
|
Headache
|
2002
|
0.79
|
|
26
|
Primary autoimmune haemolytic anaemia and coeliac disease.
|
Scand J Gastroenterol
|
2004
|
0.79
|
|
27
|
Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation.
|
J Intern Med
|
2003
|
0.79
|
|
28
|
Probiotics in antibiotic-associated diarrhoea.
|
Dig Liver Dis
|
2002
|
0.78
|
|
29
|
Accuracy of laryngeal examination during upper gastrointestinal endoscopy for premalignancy screening: prospective study in patients with and without reflux symptoms.
|
Endoscopy
|
2006
|
0.78
|
|
30
|
Elevated homocysteine levels in patients with Raynaud's syndrome.
|
J Rheumatol
|
2000
|
0.77
|
|
31
|
The role of Helicobacter pylori in cardiovascular and cerebrovascular diseases.
|
J Physiol Pharmacol
|
1999
|
0.76
|
|
32
|
Is cytotoxic-associated gene A-positive Helicobacter pylori important?
|
J Clin Gastroenterol
|
2001
|
0.75
|
|
33
|
Idiopathic thrombocytopenic purpura and Helicobacter pylori infection.
|
Scand J Gastroenterol
|
2003
|
0.75
|
|
34
|
13C-methacetin breath test and oxygen supply.
|
Aliment Pharmacol Ther
|
2003
|
0.75
|
|
35
|
Chronic infections and migraine.
|
Headache
|
2004
|
0.75
|
|
36
|
Raynaud's phenomenon and celiac disease.
|
Am J Gastroenterol
|
2003
|
0.75
|
|
37
|
Helicobacter pylori infection and vascular diseases.
|
Ital J Gastroenterol Hepatol
|
1998
|
0.75
|
|
38
|
Prevalence of and risk factors for Helicobacter pylori infection among healthcare workers at a teaching hospital in Rome: the Catholic University Epidemiological Study.
|
Eur J Gastroenterol Hepatol
|
2001
|
0.75
|
|
39
|
Improvement of mitochondrial function evaluated by ketoisocaproic acid breath test in patients with HCV infection undergoing albumin dialysis.
|
Transplant Proc
|
2005
|
0.75
|
|
40
|
Helicobacter pylori eradication and acne rosacea resolution: cause-effect or coincidence?
|
Dig Liver Dis
|
2004
|
0.75
|
|
41
|
Use of oxycodone in polytrauma patients: the "Gemelli" experience.
|
Eur Rev Med Pharmacol Sci
|
2008
|
0.75
|